In Brief
How plants transform the central biosynthetic intermediate strictosidine into thousands of divergent alkaloids has remained unresolved. Stavrinides et al. discover a nuclear-localized alcohol dehydrogenase homolog responsible for conversion of strictosidine aglycone to tetrahydroalstonine that appears to interact with an upstream pathway enzyme.
INTRODUCTION
The monoterpene indole alkaloids (MIAs) are a highly diverse family of natural products that are produced in a wide variety of medicinal plants. Over 3000 members of this natural product class, which includes compounds such as quinine, vinblastine, reserpine, and yohimbine, are derived from a common biosynthetic intermediate, strictosidine aglycone (O'Connor and Maresh, 2006) . How plants transform strictosidine aglycone into divergent structural classes has remained unresolved.
The recent availability of transcriptome and genome data has dramatically accelerated the rate at which new plant biosynthetic genes are discovered. All genes that lead to strictosidine aglycone have been recently cloned from the well-characterized medicinal plant Catharanthus roseus, which produces over 100 MIAs (De Luca et al., 2014) . However, gene products that act on strictosidine aglycone have not been identified in any plant, despite decades of effort. Attempts have been hampered in part by the reactivity and instability of strictosidine aglycone. In C. roseus, there are at least two major pathway branches derived from strictosidine aglycone (O'Connor and Maresh, 2006) . One pathway is hypothesized to lead to the aspidosperma and the iboga classes to yield the precursors of vinblastine, while the other is expected to lead to alkaloids of the heteroyohimbine type ( Figure 1A ). These alkaloids have diverse biological activities: vinblastine is used as an anticancer agent (Kaur et al., 2014) and the heteroyohimbines have a range of pharmacological uses (Costa-Campos et al., 1998; Elisabetsky and CostaCampos, 2006) . While it is unknown how many C. roseus enzymes use strictosidine aglycone as a substrate, there is clearly more than one enzyme that acts at this crucial branchpoint.
The biochemical pathway leading from strictosidine aglycone to the heteroyohimbine alkaloids has been previously investigated using both crude plant extracts and biomimetic chemistry. Reduction of strictosidine aglycone with NaBH 4 or NaCNBH 3 yielded the heteroyohimbines ajmalicine (raubasine), tetrahydroalstonine, and 19-epi-ajmalicine, which differ only in the stereochemical configuration at carbons 15, 19, and 20, in various ratios ( Figure 1B ) (Brown et al., 1977; Kan-Fan and Husson, 1978 , 1979 , 1980 . These three diastereomers were again observed, also in varying relative amounts, when crude C. roseus protein extracts were incubated with strictosidine aglycone and NADPH, but not in the absence of NADPH (Rueffer et al., 1979; Stoeckigt et al., 1976 Stoeckigt et al., , 1977 Stoeckigt et al., , 1983 Zenk, 1980) . Collectively, these observations indicate that the heteroyohimbines result directly from the reduction of strictosidine aglycone and that an NADPH-dependent enzyme is implicated in this process. However, no gene encoding such an enzyme has been identified. Here we report the discovery of a reductase that converts strictosidine aglycone to the heteroyohimbine alkaloid tetrahydroalstonine.
RESULTS AND DISCUSSION
Given that heteroyohimbine biosynthesis likely requires reduction of an iminium present in strictosidine aglycone ( Figure 1B ), we used a publically available RNA-seq database that we recently generated (Gongora-Castillo et al., 2012) to search for C. roseus candidates displaying homology to enzyme classes known to reduce the carbonyl functional group. The alcohol dehydrogenases (ADHs), enzymes that reduce aldehydes and ketones to alcohols, were chosen as the initial focus. As part of a screen of ADHs that are upregulated in response to methyl jasmonate (Gongora-Castillo et al., 2012) , a hormone known to upregulate alkaloid biosynthesis, we identified a candidate annotated as sinapyl alcohol dehydrogenase (Supplemental Information) . When heterologously expressed and purified from E. coli ( Figure S1 ), and assayed with strictosidine aglycone and NADPH, this candidate yielded a product with a mass consistent with a heteroyohimbine (m/z 353.1855), thereby implicating this enzyme in the important structural branchpoint of the MIA biosynthetic pathway (Figure 2A) .
To determine the identity of the alkaloid product, the enzyme was incubated with purified strictosidine (4.3 mg) in the presence of strictosidine glucosidase (SGD), which generated strictosidine aglycone in situ to best mimic physiologically relevant conditions. The major product (approximately 1 mg) was isolated by preparative thin-layer chromatography and exhibited an 1 H-NMR and 13 C-NMR spectrum matching an authentic standard of tetrahydroalstonine ( Figure 2B ; Figure S2 ). Hemscheidt and Zenk (1985) previously reported the isolation of an enzyme that produced tetrahydroalstonine, although this protein was purified only 35-fold from C. roseus cell cultures. Consistent with Hemscheidt and Zenk's (1985) nomenclature, we named this enzyme tetrahydroalstonine synthase (THAS). A minor enzymatic product was produced in yields too low for NMR characterization, but had a mass and R f value consistent with ajmalicine, a stereoisomer of tetrahydroalstonine ( Figure S2 ). When applied to normal phase liquid chromatography conditions, ajmalicine and tetrahydroalstonine could be resolved, indicating that the enzyme produces approximately 95% tetrahydroalstonine (Figure 3 ; Supplemental Information). We also silenced this gene in C. roseus seedlings using virus-induced gene silencing (VIGS) (Liscombe and O'Connor, 2011) . LC-mass spectrometry (MS) analysis of the silenced leaf tissue showed a statistically significant decrease (approximately 50%) of a peak with a mass and retention time consistent with a heteroyohimbine, suggesting that this enzyme is involved in this biosynthetic pathway branch in vivo ( Figure S2) . A 50% reduction in product levels upon silencing has been observed for other physiologically relevant biosynthetic genes using the VIGS approach in both C. roseus (Asada et al., 2013; Geu-Flores et al., 2012) and another well-studied medicinal plant, opium poppy (Desgagne-Penix and Facchini, 2012; Chen and Facchini, 2014) . Therefore, THAS is likely a major producer of tetrahydroalstonine in vivo, although additional, undiscovered C. roseus enzymes could also contribute to production of this compound. While we could not resolve tetrahydroalstonine and its stereoisomer ajmalicine in the silenced crude extracts, the levels of the ajmalicinederived alkaloid serpentine remain the same, suggesting that silencing of THAS does not substantially affect ajmalicine levels and consequently that THAS does not play a major role in the biosynthesis of ajmalicine in planta.
Small-scale assays using LC-MS to monitor product formation indicated that NADPH was required for the reaction, although NADH could also be utilized ( Figure S1 ). Efforts to accurately measure the steady state kinetic constants of this enzyme were complicated because strictosidine aglycone reacts with nucleophiles, opening the possibility that the substrate reacts with components in the reaction or the enzyme. This reactivity has already been associated with a plant defense mechanism involving strictosidine aglycone-mediated aggregation of proteins in C. roseus (Guirimand et al., 2010) . Nevertheless, we obtained estimated K m and k cat values ( Figure S1 ). To support these kinetic data, we also performed isothermal titration calorimetry (ITC) with THAS in the presence of NADPH and strictosidine aglycone. Titration of THAS with NADPH indicated that the cosubstrate binds first with a K d of 1.5 ± 0.1 mM (DH (cal/mol) Figure S1 ). The aglycone substrate does not appear to bind in the absence of NADPH, suggesting that the enzyme utilizes an ordered binding mechanism in which NADPH binds first. However, titration of the THAS-NADPH complex with strictosidine aglycone led to formation of a precipitate when concentrations of strictosidine aglycone exceeded 60 mM, preventing calculation of an accurate K d . Collectively, the ITC data for THAS are consistent with an ordered Bi-Bi mechanism, a kinetic mechanism that has been reported for similar ADHs such as cinnamyl alcohol dehydrogenase (Charlier and Plapp, 2000; Lee et al., 2013) .
The amino acid sequence of THAS was subjected to a BLAST alignment against the C. roseus transcriptome (Gongora-Castillo et al., 2012) , as well as the NCBI ( Figure S3 ). The closest characterized homologs of THAS are sinapyl alcohol dehydrogenase (Populus tremuloides, 64% amino acid identity), cinnamyl alcohol dehydrogenase (Populus tomentosa, 64%) and 8-hydroxygeraniol dehydrogenase (C. roseus, 63%), which are zinc-containing medium chain ADHs (Bomati and Noel, 2005; Lee et al., 2013) .
Strictosidine aglycone can rearrange into several isomers (Figure 1B) , and while it has been reported that the dominant isomer is cathenamine (Gerasimenko et al., 2002; Stoeckigt et al., 1977) , equilibration in solution with other isomers occurs (Brown and Leonard, 1979; Stoeckigt et al., 1983) . Reduction of cathenamine or epi-cathenamine ( Figure 1B ) by a reductase would require reduction of the carbon-carbon double bond of an enamine; alternatively, Stoeckigt et al. (1983) and Zenk (1980) suggested that the iminium isomer is reduced ( Figure 1B) . THAS may catalyze the stereoselective formation of tetrahydroalstonine by selectively binding the correct isomer of the substrate for reduction, thereby relying on the inherent propensity for the enamine and imine to tautomerize under physiological conditions. Given that three diastereomers, ajmalicine, tetrahydroalstonine, and 19-epi-ajmalicine, can be obtained from chemical reduction of strictosidine aglycone, this is a chemically reasonable proposal. An alternative hypothesis is that THAS catalyzes enamine-imine tautomerization in addition to reduction. The difficulties associated with obtaining accurate kinetic data in this system, as well as the inherent reactivity of the strictosidine aglycone, make answering these questions using enzymology approaches challenging. However, identification and comparison with enzymes that generate other heteroyohimbine diastereomers will likely provide the basis for a more definitive mechanism of product specificity.
Recent research has highlighted that plant secondary metabolite biosynthetic pathways often are compartmentalized in different subcellular locations. While microscopy experiments have demonstrated that most of the early steps of monoterpene indole alkaloid biosynthesis in C. roseus take place in the cytosol (Courdavault et al., 2014) , the enzyme that synthesizes strictosidine is located in the vacuole, and the enzyme SGD, which deglycosylates strictosidine, contains a nuclear localization signal and is in the nucleus, a highly unusual site for secondary metabolite biosynthesis (Guirimand et al., 2010) . Notably, a motif resembling a class V nuclear localization sequence (Kosugi et al., 2008) was observed in THAS (K 214 K 215 K 216 R 217 ). Microscopy of C. roseus cells transformed with YFP-tagged THAS confirmed the nuclear location of this enzyme, while deletion of the KKKR sequence disrupted the localization ( Figure 4A ; Figure S4 ). This is one of the very few examples of secondary metabolism that is localized to the nucleus (Saslowsky et al., 2005) . Given the reactivity of strictosidine aglycone (Guirimand et al., 2010) , metabolic channeling via a protein-protein interaction between SGD and the enzyme immediately downstream may be necessary to protect the substrate. Pull down experiments between SGD and THAS gave partially positive but inconclusive results ( Figure S4 ). However, when we used bimolecular fluorescence complementation (BiFC) in C. roseus cells, we observed an interaction between SGD and THAS ( Figure 4B ). While this interaction generated a diffuse nuclear fluorescent signal when the C-terminal end of SGD was fused to the split-YFP fragment, a sickle-shaped signal was observed when both SGD and THAS were expressed with free C-terminal ends (YFP N -SGD and YFP C -THAS). Such a signal was also observed for SGD self-interactions (Guirimand et al., 2010) and likely results from the formation of SGD complexes over 1.5 MDa (Luijendijk et al., 1998) . Similar experiments with SGD and an upstream MIA biosynthetic enzyme, loganic acid methyl transferase, failed to show an interaction, highlighting the specificity of this interaction ( Figure S4 ). The fact that THAS interacts with SGD provides further support for the physiological relevance of THAS in planta. As strictosidine aglycone is reactive and most likely toxic in vivo, it has been proposed that this molecule is produced by the plant in response to attack (Guirimand et al., 2010) . The nuclear localization of THAS might be an evolutionary mechanism designed to channel this molecule into a more stable product when no such defense is required. Identification of additional nuclear-localized biosynthetic enzymes in C. roseus and other heteroyohimbine producing plants may provide more insight into the reasons for this unusual localization pattern.
SIGNIFICANCE
Many of the monoterpene indole alkaloid structural classes are generated at the SGD junction. Here we report the first identification of a biosynthetic gene that acts directly downstream of SGD. The enzyme, an ADH homolog, generates a heteroyohimbine alkaloid by reducing one of the isomers of strictosidine aglycone. Unusually, this enzyme is located in the nucleus and may interact with its upstream partner, SGD. The discovery of the THAS gene represents the completion of a major branch of monoterpene indole alkaloid biosynthesis, which will now allow reconstruction of heteroyohimbines and heteroyohimbine analogs in heterologous hosts. This discovery is a crucial first step in understanding how the structural diversity of MIAs is controlled.
EXPERIMENTAL PROCEDURES
The THAS gene (accession number KM524258) was cloned into pOPINF and expressed in Rosetta 2 pLysS E. coli cells (Novagen) with induction of expression with 0.1 mM isopropyl b-D-1-thiogalactopyranoside. Cultures were grown at 18 C for 16 hr, with shaking at 200 rpm. His-tagged THAS was purified using a HisTrap FF 5-ml column (GE Healthcare). SGD expression and purification was done as described for THAS using the expression system described previously by Yerkes et al. (2008) . Purified THAS and SGD were used in all assays. Strictosidine was enzymatically synthesized from tryptamine and a crude methanol extract of snowberries (Symphoricarpos albus) enriched in secologanin prepared as previously described (Geerlings et al., 2001) . Strictosidine aglycone was generated in situ prior to addition of THAS by incubation of strictosidine and SGD in the appropriate solution for 10 min, at which time strictosidine was completely converted to the aglycone. Steady state kinetic analyses were performed with 50 nM THAS and 6 nM SGD, 50 mM phosphate buffer (pH 7.5), 200 mM NADPH, and an internal caffeine standard (50 mM). All LC-MS measurements were performed on AQUITY ultraperformance liquid chromatography with a Xevo TQ-S mass spectrometer.
For VIGS, a 330-bp fragment of THAS was cloned into the pTRV2u vector as described (Geu-Flores et al., 2012) . The resulting pTRV2u-THAS construct was used to silence THAS in C. roseus seedlings essentially as described (Liscombe and O'Connor, 2011) .
The subcellular localization of THAS was studied by creating fluorescent fusion proteins using the pSCA-cassette YFPi plasmid (Guirimand et al., 2009 (Guirimand et al., , 2010 . The capacity of interaction of THAS and SGD was characterized by BiFC assays using THAS PCR product cloned via SpeI into the pSPYCE(MR) plasmid (Waadt et al., 2008) , which allows expression of THAS fused to the carboxy-terminal extremity of the split YFP C fragment (YFP C -THAS). The pSCA-SPYNE173-SGD and pSPYNE(R)173-SGD plasmids (Guirimand et al., 2010) were used to express SGD fused to the amino-terminal or carboxy-terminal extremity of the split YFP N fragment (SGD-YFP N and YFP N -SGD, respectively). THAS self-interactions were analyzed via additional cloning of the THAS PCR product into the pSCA-SPYNE173 and pSCA-SPYCE(M) plasmids (Guirimand et al., 2010) to express THAS-YFP N and THAS-YFP C , respectively. Transient transformation of C. roseus cells by particle bombardment and fluorescence imaging were performed following the procedures previously described (Guirimand et al., 2009 (Guirimand et al., , 2010 .
Complete experimental details are included in the Supplemental Information.
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A.
1 H NMR Comparison of the major enzymatic product (bottom trace) with authentic standard of tetrahydroalstonine (top trace), aromatic region. B. Characterization of the major product by 13 C NMR. C. Large-scale production for NMR characterisation isolated by preparative thin layer chromatography using UV detection. Reaction by products are likely decomposition products of strictosidine aglycone. D. Real time PCR showing downregulation of THAS in silenced (VIGS) leaves. Relative gene expression level of THAS in C. roseus leaves that have been inoculated with pTRV2 Empty vector (EV) and pTRV2-THAS. The decrease of THAS gene expression due to VIGS is ≈ 85% compared to EV. E. Mass spectrometry profiles of silenced and empty vector control leaves that show statistically significant decrease in heteroyohimbine levels (P value 0.00199). The two diastereomers, ajmalicine and tetrahydroalstonine, cannot be separated under a variety of conditions on LCMS (see Supplemental Results). A peak corresponding to serpentine (m/z 349), which is derived from ajmalicine, does not significantly decrease in response to silencing of THAS. While these data indicate that THAS is involved in tetrahydroalstonine biosynthesis in vivo, we do not rule out the existence of additional C. roseus enzymes that catalyze tetrahydroalstonine formation. Millipore, Massachusetts, USA). A starter culture was grown overnight at 37˚C in 20 mL of LB media supplemented with carbenicillin and chloramphenicol (100 μg/mL and 34 μg/mL respectively). A 1:100 dilution in fresh LB media supplemented with antibiotics was prepared and allowed to grow at 37˚C to an OD 600 of 0.6. Before induction of expression with 0.1 mM IPTG, the cultures were cooled to 18˚C and kept at this temperature until harvest, with 200 rpm shaking. After 16 h the cells were collected by centrifugation and resuspended in 50 mL Buffer A (50 mM Tris-HCl pH 8, 50 mM glycine, 500 mM NaCl, 5% glycerol, 20 mM imidazole) along with a tablet of protease inhibitor (Roche Diagnostics Ltd.). Cells were lysed using sonication for 3 minutes on ice using 2 s pulses. All purification steps were performed at 4˚C on an ÄKTAxpress purifier (GE Healthcare). His-tagged THAS was purified using a HisTrap FF 5 mL column (GE Healthcare) equilibrated with Buffer A. The sample was loaded at a flow rate of 4 mL/min and step-eluted with Buffer B (50 mM Tris-HCl pH 8, 50 mM glycine, 500 mM NaCl, 5% glycerol, 500 mM imidazole). Eluted protein was subjected to further purification on a Superdex Hiload 26/60 S75 gel filtration column (GE Healthcare) at a flow rate of 3.2 mL/min using Buffer C (20 mM Hepes pH 7.5, 150 mM NaCl) and collected into 8 mL fractions. After analysis by SDS-PAGE, those fractions containing no traces of other contaminating proteins were pooled and concentrated in a 10 KDa cutoff Millipore filter (Merck Millipore) and concentration was measured using a BCA assay (Thermo Fisher Scientific Inc., USA).
C. Enzyme assays
Purified THAS and purified SGD were used in all assays. Strictosidine was purified by preparative reverse phase HPLC and quantified using 1 H NMR. Strictosidine aglycone was generated in situ prior to addition of THAS by incubation of strictosidine and SGD in the appropriate solution for ten minutes, at which time strictosidine was completely converted to the aglycone. Steady state kinetic analyses were performed with 50 nM of THAS and 6 nM of SGD, 50 mM phosphate buffer (pH 7.5), 200 μM NADPH and an internal standard (50 μM caffeine). SGD has been shown to have a pH optimum between 6 and 8.5 (Luijendijk et al., 1998) and therefore should exhibit optimal activity at pH = 7.5. The kinetics were performed as follows: varying concentrations of strictosidine was placed in the wells of a 96-well plate with 50 mM phosphate buffer, followed by addition of 6 nM of SGD and the necessary volume of MilliQ water to standardize the volume. Caffeine (50 μM) was added to this mix as an internal standard. Another set of wells was prepared that contained pre-mixed solutions of 50 nM of THAS and 200 μM of NADPH. After 10 minutes of incubation with SGD, the strictosidine mix was added to the THAS + NADPH mix and mixed by pipetting several times. At 0.5 minutes, one minute and two minutes, a 10 μL aliquot of the reaction was placed in 80 μL H 2 0 + 0.1% formic acid premixed with 10 μL of methanol for a 10-fold final dilution of the sample. The 96-well plate was centrifuged at 4000 rpm for 10 min to pellet the enzyme precipitate and then analyzed by LCMS.
A similar procedure was used to determine the K m for NADPH, using 300 μM strictosidine and varying the NADPH concentration. The initial rate of the reaction (V 0 ) was calculated by fitting a linear regression through the points of product formation plotted against time. Michaelis-Menten plots were performed using SigmaPlot (Systat Software Inc.).
D. UPLC-QqQ-MS/MS analysis of the enzyme assays
Ultraperformance liquid chromatography (UPLC) was performed on a Waters Acquity UPLC system (Milford, MA) consisting of a binary pump, an online vacuum degasser, an autosampler, and a column compartment.
Kinetic studies and reaction monitoring
Chromatography was performed a BEH Shield RP18 (50 x 2.1 mm; 1.7 μm) column (Waters). The solvents used were H 2 O + 0.1% formic acid as Solvent A and 100%
acetonitrile as Solvent B, with a flow rate of 0.6 mL/min. Injection volume was 2 µL.
The gradient profile was 0 min, 5% B; from 0 to 3.5 min, linear gradient to 35% B; from 3.5 min to 3.75 min, linear gradient to 100% B; wash at 100% B for 1 min; from 4.75 min to 6 min, back to 5% B for 1 min to re-equilibrate the column.
Quantification of tetrahydroalstonine: ajmalicine ratio
Separation of tetrahydroalstonine from ajmalicine could be achieved on a Luna NH2
(100 x 2.0 mm; 3 μm) column (Phenomenex). The chromatography was performed in HILIC mode using isocratic elution with 1% Solvent A and 99% Solvent C (50% acetonitrile + 50% isopropanol +0.1% formic acid) at a flow rate of 0.350 mL/min. The injection volume of both the standard solutions and the samples was 1 μL.
Mass spectrometry detection was performed on a Waters Xevo TQ-S mass spectrometer (Milford, MA, USA) equipped with an electrospray (ESI) source.
Capillary voltage was 2.5 kV in positive mode; the source was kept at 150 °C; desolvation temperature was 500 °C; cone gas flow, 50 L/h; and desolvation gas flow, 900 L/h. Unit resolution was applied to each quadrupole.
Targeted methods for each compound were developed using either commercial standards (caffeine, ajmalicine and tetrahydroalstonine were purchased from SigmaAldrich) or enzymatically produced compounds (strictosidine and strictosidine aglycone). Flow injections of each individual compound were used to optimize the MRM conditions. This was done automatically using the Waters Intellistart software.
A minimum dwell time of 25 ms was applied to each MRM transition. E. Large-scale product purification A large-scale reaction was setup for production of the THAS product: 4.3 mg of strictosidine was diluted in 20 mL of distilled water (400 μM), 500 μM NADPH, 3 nM of SGD, 100 nM of THAS, 20 units of Glucose-6-Phosphate Dehydrogenase (Roche Diagnostics), and 1 mM of glucose-6-phosphate was added to the reaction mix and the pH was adjusted to 7.5 using 50 mM phosphate buffer. The reaction was incubated with gentle shaking at room temperature and reaction progress was assessed by subjecting aliquots to LCMS analysis. After 5 hours the reaction reached completion, and was quenched by addition of two volumes of methanol. The reaction was concentrated by evaporating to dryness under vacuum. The dried precipitate was extracted with methanol (1 mL) and the supernatant transferred to a clean round-bottom flask. Extraction of the precipitate was repeated until the extraction volume was approximately 15 mL. To the remaining precipitate was added 2 mL of water, followed by 2 mL of ethyl acetate (HPLC grade). The fractions were mixed gently and allowed to separate. Extraction of the water fraction with ethyl acetate was repeated 5 times, and the combined organic fractions were dried under vacuum and then resuspended in 50 μL of ethyl acetate. This was loaded onto a preparative silica TLC plate (UNIPLATE, Analtech™) that was pre-soaked with triethylamine (TEA).
The TLC plate was developed in ethyl acetate : hexanes : TEA (24 : 75 : 1), twice, and allowed to air dry between runs. Visualisation of the bands was performed using UV (254 nm). A minor product with m/z 353, which had an identical R f value to ajmalicine, was also observed, but could not be isolated in sufficient quantities for NMR.
F. NMR characterization
The major product of the reaction was excised from the TLC plate with a scalpel, and the silica was extracted with 2 mL of ethyl acetate five times. The ethyl acetate was filtered through filter paper to remove the silica. After drying under vacuum, the product was resuspended in 200 μL of fresh ethyl acetate and passed through an SP column that was pre-equilibrated with hexanes (HPLC grade). indirectly, that ajmalicine production is not substantially affected by this VIGS experiment (Fig. S2D ).
I. Quantitative real-time PCR
RNA extraction was performed using the RNeasy Plant Mini Kit (Qiagen). RNA (1 μg) was used to synthesize cDNA in 20 μL reactions using the iScript cDNA Synthesis Kit (Bio-Rad). The cDNA served as template for quantitative PCR performed using the CFX96 Real Time PCR Detection System (Bio-Rad) using the SSO Advanced SYBR Green Supermix (Bio-Rad). Each reaction was performed in a total reaction volume of 20 μL containing an equal amount of cDNA, 0.25 mM forward and reverse primers, and 1x SsoAdvanced SYBRGreen Supermix (Bio-Rad). The reaction was initiated by a denaturation step at 95˚C for 10 min followed by 41 cycles at 95˚C for 15 s and 60˚C for 1 min. Melting curves were used to determine the specificity of the amplifications. Relative quantification of gene expression was calculated according to the delta-delta cycle threshold method using the 40S ribosomal protein S9 (RPS9).
The primers 5'-TTGAGCCGTATCAGAAATGC-3' and 5'-CCCTCATCAAGCAGACCATA-3' were used for RPS9, and 5'-TGACAGTGATTAGTTCTTCACTTAAGA-3' and 5'-TGCACCCTGCATTTCTTC-3' were used for THAS. All primer pair efficiencies were between 98% and 108%, and the individual efficiency values were considered in the calculation of normalized relative expression, which was performed using the Gene Study feature of CFX Manager Software. All biological samples were measured in technical duplicates.
J. Isothermal Titration Calorimetry (ITC)
Titration was performed using a MicroCal iTC200 System (GE Healthcare Life Sciences) by injecting 2 μL of titrant at intervals of 110 s. The first injection was 0.5 μL and not used for data analysis. Titrations were carried out at 30˚C, and stirring speed was 700 rpm. For determination of the dissociation constant of THAS and NADPH, THAS was dialyzed overnight against 2 L of Buffer C (20 mM Hepes (pH 6.8), 100 mM NaCl). The protein concentration was adjusted with dialysis buffer before the experiment. THAS dimer (40 µM) was titrated with 1 mM of NADPH (dissolved in Buffer C). Titrations were carried out in triplicate and a control titration was carried out in which Buffer C was injected into the cell containing THAS in order to determine the dilution or mixing heat. This heat was then subtracted from the analysis of the NADPH titrations. Data analysis was done using Origin 7.0 software K. Pull down of THAS with SGD Purified THAS was prepared for pull-down assay by cleaving the His-tag using 3C
protease. THAS (200 μg) was incubated with 3C protease (1 μg) overnight at 4˚C, then 1 μg of fresh 3C protease was added and the reaction was allowed to progress for another thirty minutes at room temperature.
To purify the cleaved THAS, the reaction was passed through a 0.5 mL Ni-NTi Agarose slurry (Qiagen Ltd., Manchester, UK) pre-equilibrated with Buffer D (20 mM Hepes (pH 7.5), 150 mM NaCl). The flow through was collected and an aliquot was analyzed by SDS-page gel to verify the molecular weight. Cleaved THAS was concentrated using a Millipore filter unit with a 10 KDa cutoff and the concentration measured using a BCA assay. A glass chromatography column (0.5 cm x 10 cm) was loaded with 0.5 mL of Ni-NTi Agarose slurry (Qiagen) that was washed and equilibrated with 15 mL of Buffer D. His-tagged SGD (380 μg) was loaded onto the column and 1 mL fractions were collected. The column was then washed with 5 mL of Buffer C, followed by loading of 100 μg of THAS, premixed with 0.5 mM of NADPH. The column was washed with 5 mL of Buffer D and elution was carried out with 3 mL of buffer E (20 mM Hepes (pH 7.5), 150 mM NaCl, 250 mM imidazole).
Aliquots (20 µL) of each fraction were analyzed by SDS-page gel and stained using InstantBlue (Expedeon Ltd, Cambridgeshire, UK).
L. Subcellular localization, NLS mutation and analysis of protein-protein interactions using bimolecular fluorescent complementation (BiFC) assays
The full-length ORF of THAS was amplified using the specific primers 5'-CTGAGAACTAGTATGGCAATGGCTTCAAAGTCAC-3' and 5'-CTGAGAACTAGTATTTGATTTCAGAGTGTTCCCTATATCAATC-3', which were designed to introduce the SpeI restriction site at both cDNA extremities. The PCR product was sequenced and cloned at the 5' end of the yellow fluorescent protein Transient transformation of C. roseus cells by particle bombardment and fluorescence imaging were performed following the procedures previously described (Guirimand et al., 2009; Guirimand et al., 2010) . Briefly, C. roseus plated cells were bombarded with DNA-coated gold particles (1 µm) and 1,100 psi rupture disc at a stopping-screen-to-target distance of 6 cm, using the Bio-Rad PDS1000/He system.
Cells were cultivated for 16 h to 38 h before being harvested and observed. The subcellular localization was determined using an Olympus BX-51 epifluorescence microscope equipped with an Olympus DP-71 digital camera and a combination of YFP and CFP filters. The pattern of localization presented in this work is representative of circa 50 observed cells. The nuclear or nucleocytosolic localizations of the different fusion proteins were confirmed by co-transformation experiments using the nuclear-CFP marker and the nucleocytosolic CFP marker (Guirimand et al., 2010) . Such plasmid co-transformations were performed using 400 ng of each plasmid or 100 ng for BiFC assays. Plasmids encoding bZIP63-YFP N and bZIP63-YFP C were used as controls (Waadt et al., 2008) .
